Literature DB >> 9447425

Diagnosis of Alzheimer's disease. Report of an International Psychogeriatric Association Special Meeting Work Group under the cosponsorship of Alzheimer's Disease International, the European Federation of Neurological Societies, the World Health Organization, and the World Psychiatric Association.

B Reisberg1, A Burns, H Brodaty, R Eastwood, M Rossor, N Sartorius, B Winblad.   

Abstract

Current knowledge with respect to the diagnosis of Alzheimer's disease (AD) is reviewed. There is agreement that AD is a characteristic clinicopathologic entity that is amenable to diagnosis. The diagnosis of AD should no longer be considered one of exclusion. Rather, the diagnostic process is one of recognition of the characteristic features of AD and of conditions that can have an impact on presentation or mimic aspects of the clinicopathologic picture. The present availability of improved prognosis, management, and treatment strategies makes the proper, and state-of-the-art, diagnosis of AD a clinical imperative in all medical settings. Concurrently, information regarding the relevance and applicability of current diagnostic procedures in diverse cultural settings must continue to accrue.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9447425     DOI: 10.1017/s1041610297004675

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  12 in total

1.  A Swedish programme for dementia diagnostics in primary healthcare.

Authors:  Erik Jedenius; Anders Wimo; Jan Strömqvist; Niels Andreasen
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

2.  Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study.

Authors:  Martin R Farlow; Stephen Salloway; Pierre N Tariot; Jane Yardley; Margaret L Moline; Qin Wang; Elimor Brand-Schieber; Heng Zou; Timothy Hsu; Andrew Satlin
Journal:  Clin Ther       Date:  2010-07       Impact factor: 3.393

3.  REPS1 as a Potential Biomarker in Alzheimer's Disease and Vascular Dementia.

Authors:  Jiefeng Luo; Liechun Chen; Xiaohua Huang; Jieqiong Xie; Chun Zou; Mika Pan; Jingjia Mo; Donghua Zou
Journal:  Front Aging Neurosci       Date:  2022-06-22       Impact factor: 5.702

4.  Factor structure and invariance of the Quality of Life in Alzheimer's Disease (QoL-AD) Scale.

Authors:  Andrew J Revell; Grace I L Caskie; Sherry L Willis; K Warner Schaie
Journal:  Exp Aging Res       Date:  2009 Apr-Jun       Impact factor: 1.645

5.  Cost effectiveness of memantine in Alzheimer's disease: an analysis based on a probabilistic Markov model from a UK perspective.

Authors:  Roy W Jones; Paul McCrone; Chantal Guilhaume
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

6.  Cost effectiveness of memantine in moderately severe to severe Alzheimer's disease : a markov model in Finland.

Authors:  Clément François; Harri Sintonen; Raimo Sulkava; Benoît Rive
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

7.  Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer's disease.

Authors:  Pierre Tariot; Steven Salloway; Jane Yardley; Joan Mackell; Margaret Moline
Journal:  BMC Res Notes       Date:  2012-06-08

Review 8.  Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research.

Authors:  Avinash Parimisetty; Anne-Claire Dorsemans; Rana Awada; Palaniyandi Ravanan; Nicolas Diotel; Christian Lefebvre d'Hellencourt
Journal:  J Neuroinflammation       Date:  2016-03-24       Impact factor: 8.322

9.  Effects of Degree of Urbanization and Lifetime Longest-Held Occupation on Cognitive Impairment Prevalence in an Older Spanish Population.

Authors:  Laura Lorenzo-López; José C Millán-Calenti; Rocío López-López; Clara Diego-Diez; Blanca Laffon; Eduardo Pásaro; Vanessa Valdiglesias; Ana Maseda
Journal:  Front Psychol       Date:  2017-02-13

10.  Clinical evaluation of patients with moderate to severe Alzheimer disease.

Authors:  Paulo Rogério Borges Rosmaninho Varandas; Rossana Russo Funari
Journal:  Dement Neuropsychol       Date:  2007 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.